# DESCRIPTION

## FIELD OF THE INVENTION

- relate to method for modulating insulin-independent glucose transport

## BACKGROUND OF THE INVENTION

- introduce teneurins
- describe structure and function of teneurins
- discuss role of teneurins in nervous system
- describe importance of skeletal muscle in glucose homeostasis
- highlight need for new therapies for diabetes and muscle disorders

## SUMMARY OF THE INVENTION

- introduce method for increasing energy available to skeletal muscle cells
- describe use of TCAP to increase glucose uptake
- outline method for administering TCAP to patients
- describe pharmaceutical composition comprising TCAP
- highlight benefits of increasing energy available to skeletal muscle cells
- outline various embodiments of the invention

## DETAILED DESCRIPTION OF THE INVENTION

- describe TCAP's effect on energy available to muscles
- describe TCAP's role in regulating energy metabolism in mammals
- describe TCAP's potential in treating muscle fatigue, insulin resistance, and diabetes

### Definitions

- define "administering to the cell(s)"
- define "effective amount" and "therapeutically effective amount"
- define "homeostasis"
- define "insulin resistance" and "muscle fatigue"
- define "obvious chemical equivalents" and "pharmaceutically acceptable carrier"

### Applications: The Use of TCAP to Increase Energy Available to Skeletal Muscle Cells

- describe the importance of glucose uptake in skeletal muscle cells
- describe the potential applications of increasing glucose uptake in skeletal muscle cells
- describe the method of increasing energy available to skeletal muscle cells using TCAP
- describe the potential benefits of TCAP in promoting recovery from muscle trauma or exercise-induced injury
- describe the potential benefits of TCAP in treating glycogen storage disorders or hypoxia

### Pharmaceutical Compositions and Modes of Administration

- describe the use of TCAP, pharmaceutically acceptable salts or esters, or obvious chemical equivalents
- describe the administration of TCAP by any means that produce contact with the agent's sites of action
- describe the formulation of TCAP for sustained release or delivery locally or systemically
- describe the administration of TCAP to the site of action or through a mode of delivery
- describe the use of a nucleotide encoding TCAP or other substances that enhance TCAP expression

## EXAMPLES

### Example 1—Peptide Synthesis

- synthesize mouse TCAP-1 peptide
- determine sequence of mouse TCAP-1
- synthesize mouse paralogue of TCAP-1
- synthesize rat K37-OT K8-TCAP-1 peptide
- biotinylate K37-TCAP-1 peptide
- create scrambled TCAP peptide
- produce TCAP-1 antisera
- determine binding specificity of antisera
- conjugate FITC to TCAP-1 peptide
- study uptake of TCAP-1 in plasma
- perform intravenous and subcutaneous studies
- describe peptide synthesis
- detail autoradiography procedure
- outline functional positronic emission tomography studies
- describe PET image acquisition and analysis
- detail RT-PCR RNA extraction
- outline reverse transcription and PCR
- describe signal transduction studies
- detail MEK-ERK-AMPK phosphorylation
- outline DAG IP3 assays
- describe BCA assay
- detail ELISAs
- outline DAG assay
- describe IP3 assay
- detail Fluo-4 fluorescence measurements

### Example 2—In-Vivo Experiments

- introduce animal studies
- describe TCAP-1 uptake in plasma and brain
- measure glucose uptake in brain using fPET scans
- analyze glucose uptake in different brain regions
- compare glucose uptake between vehicle and TCAP-1 treated animals
- discuss potential interactions with 5-HT and dopaminergic regulation
- summarize results of in-vivo experiments

### Example 3—Effect of TCAP on Blood Glucose Levels

- introduce in-vivo experiments on blood glucose levels
- describe experimental design and procedures
- measure blood glucose levels using OneTouch Ultra2 system
- analyze blood glucose levels over time
- compare blood glucose levels between vehicle and TCAP-1 treated animals
- summarize results of blood glucose level experiments

### Example 4—Glucose Insulin and Glucagon Changes in Blood

- analyze changes in glucose, insulin, and glucagon levels in blood

### Example 5—Liver and Muscle Glycogen Content in Extracted Liver of TCAP-1 Treated Wistar Rats

- measure glycogen content in liver and muscle tissue

### Example 6—Haematology Assays

- perform haematology assays on rat serum

### Example 7—Localization of TCAP in Muscle Tissue

- perform fluorescent immunohistochemistry study on muscle tissue

### Example 8—Localization of TCAP-1 Relative to β-Dystroglycan in Skeletal Cells

- perform fluorescent immunohistochemistry study on skeletal cells

### Example 9—Localization of TCAP-1 Relative to Rapsyn in Skeletal Cells

- introduce TCAP-1 localization experiment
- describe immunoreactivity co-staining of TCAP-1 and rapsyn
- present results of TCAP-1 immunoreactivity on sarcolemma
- present results of rapsyn localization on sarcolemma
- show co-localization of TCAP-1 and rapsyn
- describe FIG. 9A as DIC
- introduce Example 10
- establish hypo-E38 cells as a model
- investigate expression of teneurins, TCAP, and latrophilin-1
- examine co-localization of FITC-TCAP-1 with latrophilin-1
- describe glucose uptake in cells
- examine effect of TCAP-1 on glucose uptake
- discuss results of glucose uptake experiments
- introduce TCAP-1 treatment effects
- describe lactate concentration measurement
- describe pyruvate concentration measurement
- present results of TCAP-1 treatment on lactate and pyruvate levels
- describe ATP production measurement
- present results of TCAP-1 treatment on ATP production
- describe experimental design for lactate and pyruvate assays
- describe lactate assay protocol
- describe pyruvate assay protocol
- introduce MEK inhibition effect on TCAP-1-induced glucose uptake
- describe MEK inhibition experiment protocol
- present results of MEK inhibition on glucose uptake
- describe effect of TCAP-1 on MEK-dependent AMPK phosphorylation
- describe western blot analysis protocol
- describe effect of TCAP-1 on glucose uptake in muscle cells
- introduce TCAP-1 localization in skeletal cells
- results of C2C12 myocytes treatment with TCAP-1
- effect of TCAP-1 on ERK phosphorylation in C2C12 myocytes
- western blot analysis of ERK phosphorylation
- energy associated behavior in rats
- sucrose preference and forced swim test results
- discussion of results
- glucose-lowering effect of TCAP-1 administration
- in vitro glucose uptake into hypothalamic neurons and skeletal myocytes
- GLUT3 expression in hypothalamic neurons
- MEK inhibition prevents glucose uptake into hypothalamic neurons
- TCAP-1 localization in skeletal muscle
- glucose transport into skeletal muscle
- role of AMPK in skeletal muscle
- potential candidates for treating type 2 diabetes
- role of TCAP-1 in muscle physiology
- purpose of the study
- objectives of the study
- in vivo administration of TCAP-1
- in vitro glucose uptake studies
- characterization of TCAP-1 in skeletal muscle
- potential pathway by which TCAP-1 signals in skeletal muscle
- modulation of stress response by TCAP-1
- introduce GK rats
- describe blood parameters after TCAP-1 administration
- motivate fPET study
- describe fPET study results
- discuss brain regions of TCAP-1 action
- introduce in vivo experiments
- describe animal handling and stress response
- motivate jugular vein catheter usage
- describe catheter usage and limitations
- discuss alternative blood collection methods
- introduce glucose uptake studies
- describe TCAP-1 effects on glucose uptake
- compare TCAP-1 and insulin effects
- discuss potassium-mediated depolarization
- introduce lactate assays
- describe lactate assay results
- discuss pyruvate and LDH activity
- introduce GLUT3 and GLUT1 studies
- describe GLUT3 and GLUT1 results
- discuss MEK/ERK1-2 pathway and GLUT3
- introduce AMPK pathway studies
- describe AMPK pathway results
- introduce TCAP-1 treatment in C2C12 myocytes
- compare glucose uptake in C2C12 myocytes and mHypoE-38 neurons
- discuss potential causes of variability in glucose uptake data
- describe FITC-TCAP-1 binding studies on sectioned mouse gastrocnemius muscle
- show co-localization of FITC-TCAP-1 and β-DG
- discuss immunoreactivity studies on endogenous TCAP-1 in skeletal muscle
- analyze western blot results for MEK-ERK1/2 pathway activation
- discuss complexity of MEK/ERK1-2 signalling pathway
- summarize implications of in vitro experiments on TCAP-1 effects
- discuss potential role of TCAP-1 in glucose homeostasis
- describe astrocyte-neuron-lactate shuttle and glucose metabolism in brain
- discuss regulation of glucose metabolism in skeletal muscle
- summarize conclusions on TCAP-1 effects on glucose metabolism
- discuss potential applications of TCAP-1 in clinical cases

